Two apparently independent mechanisms of instability are recognized in colorectal cancer, microsatellite instability and chromosomal instability. Evidence from colorectal cancer cell lines indicates the presence of either, or both, types of instability in the vast majority. Here, we sought to determine the prevalence of such instability in primary sporadic colorectal cancers. Microsatellite instability was established by demonstration of ovel clonal, nongerm-line alleles in at least two of four tested loci. Chromosomal abnormalities were identi®ed by comparative genomic hybridization (CGH) and¯ow cytometric analysis of nuclear DNA content. Tumours harbouring chromosomal instability were distinguished from those with stable but aneuploid karyotypes by comparing chromosomal defects at multiple sites throughout each cancer. This analysis allowed assessment of both the number of chromosomal abnormalities and their heterogeneity throughout the tumour. The results con®rm that microsatellite instability is consistently associated with multiple, repeated changes in microsatellites throughout the growth of the aected colorectal carcinomas. There were also several carcinomas in which major structural or numerical abnormalities in chromosomes had clearly continued to arise during tumour growth. However, a substantial subset of tumours showed neither microsatellite instability nor multiple, major chromosomal abnormalities. We suggest that the development of a proportion of colorectal cancers proceeds via a dierent pathway of carcinogenesis not associated with either of the currently recognized forms of genomic instability.
Introduction
The development of genetic instability has been proposed as an important event in multi-step carcinogenesis (Loeb, 1991; Hartwell, 1992) . In human colorectal carcinoma (probably the human tumour most intensively studied at the genetic level) two major mechanisms of genomic instability have been identi®ed. The ®rst, known as microsatellite instability (MIN), manifests as a high rate of alteration in the length of short tandemly repeated nucleotide sequences Ionov et al., 1993; Thibodeau et al., 1993; Eshleman et al., 1995) . Such instability is a characteristic of tumours from patients with Hereditary Non-Polyposis Colorectal Cancer (HNPCC) where it is consequent upon germ-line mutations in DNA mismatch repair (MMR) genes (hMSH2, hMLH1, hPMS1, hPMS2, hMSH3 or hMSH6) Bronner et al., 1994; Nicolaides et al., 1994; Nystrom-Lahti et al., 1994; Papadopoulos et al., 1994; Wijnen et al., 1995; Liu et al., 1996; Akiyama et al., 1997; Miyaki et al., 1997) . Defects in these genes result in multiple inaccuracies in replication of such tandem arrays, creating frameshifts and, occasionally, point mutations: the RER+ phenotype. Many genes include potential target sequences for this type of error, and mutation in some of these may confer growth advantage, and so be selected for during tumorigenesis Togo et al., 1996; Rampino et al., 1997) . The RER+ phenotype is also detected in 15 ± 20% of sporadic colorectal cancers Aaltonen et al., 1994; Wu et al., 1994; Borresen et al., 1995; Bubb et al., 1996; Konishi et al., 1996; Liu et al., 1996) . Here, its origins are conjectural, although acquired bi-allelic mutation in mismatch repair genes is responsible for some, and suppression of their activity by other mechanisms appears to occur in the majority of the remainder (Thibodeau et al., 1998) .
The majority of sporadic colorectal cancers, however, do not show the RER+ phenotype. RER7 colorectal cancers, unlike RER+ tumours, frequently show major abnormalities in chromosome structure and number, and it has been suggested that these tumours arise through chromosomal instability (CIN). Loss of a mitotic checkpoint may account for repeated errors in chromosome disjunction in many of these tumours, and loss of function of hBUB1, a critical mitotic checkpoint gene, has been observed in a small proportion of colorectal cancer cell lines exhibiting chromosomal instability (Cahill et al., 1998) . However, other mechanisms must exist, permitting the growth of clones of cells that have sustained chromosome breakage, fusion, deletion and ampli®cation events. Telomere erosion, hypomethylation and dysfunction of p53 (all phenomena that are observed frequently and at an early stage in carcinoma development) may all be permissive for these events.
In this paper we demonstrate substantial heterogeneity amongst RER7 colorectal cancers. To avoid distortion due to selection for growth potential in vitro, we based our study on primary colorectal tumours, removed at potentially curative operations from otherwise unselected patients. In classifying these tumours we devised means of estimating the extent of chromosome change based upon multiple sampling (to measure clonal divergence) and, in some instances, sampling of xenografts to detect sequential changes in real time. We identify around one third of RER7 cancers in which the extent and frequency of chromosome change is much less than the majority, and close to that observed in many RER+ tumours.
Results

Numerical measurement of chromosome instability
To quantify and compare the level of chromosomal instability in both groups of colorectal cancer we ®rst carried our comparative genomic hybridization (CGH) analysis on samples collected from multiple sites from each tumour. The mean number of chromosomal changes would be expected to be high in tumours with underlying chromosomal instability and might vary between dierent sites sampled from the same tumour due to clonal divergence. However, the presence of chromosomal changes might equally represent a single catastrophic genomic event, resulting in an aneuploid but stable genome subsequently carried by all or the majority of tumour cells. In such cases, chromosomal changes would be expected to be similar in all or the majority of the sites examined. To distinguish these events we scored separately the sum of the mean number of chromosomal arm gains and losses detected in each tumour and a heterogeneity score, which was the number of particular chromosomal changes which were not consistent between dierent sites within a tumour (for example see Figure 1 ). Added together, these two scores constituted a`chromosomal instability index'. A high heterogeneity score indicates an ongoing process of chromosomal gain and loss, despite the fact that some of the changes might have been selected for early during tumour progression. In practice, the majority of tumours showed heterogeneity scores roughly proportional to their mean numbers of chromosomal gains and losses. In such tumours, either score would provide a measure of`chromosome instability' (Figure 2) . In a small number of tumours, however, despite sampling at a similar number of sites to the majority, high numbers of gains and losses were not accompanied by pronounced intratumoral heterogeneity, showing that these two parameters could in some circumstances be independent.
Chromosomal instability in RER+ and RER7 tumours
The mean number of chromosomal changes, heterogeneity scores and the combined CIN index scores in relation to the tumours' RER status are shown in Table 1 . The mean number of chromosomal gains and losses and the CIN index were both signi®cantly higher in RER7 colorectal cancers compared with RER+ tumours (one-tailed Mann-Whitney Test, P=50.05 for both comparisons). Scores for RER7 tumours were scattered over a wide range, however, and we identi®ed a substantial subgroup with low CIN indices ( Figure 3) . A tumour's CIN index was deemed to be low if it fell below an arbitrary value of 18 (which was the mean CIN index in RER+ cancers, a group generally believed to have little chromosomal instability).
CGH measures only relative abundances of DNA and would not identify as abnormal perfect tetraploid or octapoid genomes. We therefore carried out¯ow cytometric analysis of the nuclear DNA content of all tumour samples (Table 2a,b). As expected, the cells of most of the RER+ tumours showed near-diploid DNA content although, as recorded by ourselves and others elsewhere, abnormalities detectable by CGH were frequently present. The proportion of tumours with aneuploid content was signi®cantly higher in the RER7 group of tumours compared to RER+ cancers (two-tailed Fisher exact test, P=50.05). Most RER7 colorectal cancers with a low CIN index (four out of six) and all RER+ tumours with CIN index 518 showed diploid DNA content. Figure 1 Example calculation of heterogeneity score and CIN index. CGH results in a primary tumour (tumour no. 1) sampled at four dierent sites, and in its four corresponding xenografts. Chromosome arms are represented vertically in columns, whilst each dierent site of the same tumour designated a, b, c and d are in rows. 1xa, 1xb, 1xc, and 1xd are the corresponding xenografts established from sites a, b, c and d. The heterogeneity score was calculated for the primary tumour and, separately, for the xenograft by adding together the number of columns representing chromosome arms in which changes were inconsistent between dierent sites within the tumour. In this primary tumour, inconsistent chromosome changes were present in chromosome arms 1p, 3p, 4p, 5p, 5q, 6p, 6q, 7p, 8p, 8q, 10p, 10q, 11p, 11q, 12p, 12q, 14q, 15q, 17p, 17q, 18p, 19p, 19q, 20q and 22q, giving a total heterogeneity score of 25. Consistent patterns, such as are present in 1q or 7q, do not score. CIN index was then calculated by adding together the mean number of chromosomal gains and losses and the heterogeneity score p53 status and chromosomal instability in RER7 and RER+ colorectal cancer
To investigate the role of p53 in chromosomal instability, we classi®ed tumours as showing evidence of abnormality in p53 by three criteria; stabilization of the p53 protein as detected by immunohistochemistry, mutation analysis of exons 5 ± 8 of the p53 gene (screened by single stranded conformational polymorphism analysis, SSCP) and loss of the short arm of chromosome 17. The proportion of RER7 and RER+ tumours with a p53 defect (mutation or immunohistochemical stabilization) was not signi®-cantly dierent (10/17 and 2/5, respectively) (Table 2a,b). The proportion of p53-defective tumours was signi®cantly higher (10/13) among tumours with high CIN (above 18) compared to tumours with a low CIN index (2/9), regardless of RER status (two-tailed Fisher exact test, P50.05). Tumours in which CGH revealed 17p loss, but which showed no positive IHC staining or presence of a mutation in exons 5 ± 8 of the p53 gene are indicated in Table 2 as n*, but for the purpose of statistical analysis were treated as not defective for p53.
Clinicopathological features and chromosomal abnormalities in RER7 tumours with low levels of chromosomal instability
Of the 22 primary colorectal carcinomas studied, eight were right-sided and 14 left-sided (Table 2a,b) . Clinicopathological features of RER+ sporadic colorectal cancers have been described in detail Aaltonen et al., 1994; Kim et al., 1994; Senba et al., 1998) and our data are in concordance with these results (Table 2b) : of the ®ve studied, all were rightsided, four were near-diploid in DNA content, four were poorly dierentiated and one showed abundant mucinous dierentiation. The 6 RER7 cancers with low CIN index were uniformly left-sided (compared with eight of 11 high-CIN RER7 tumours [ Table 2a ]) and mostly rectal. There was no signi®cant dierence between the low CIN index and high CIN index RER7 cancers with regard to Dukes' stage or patient age. Four RER7 cancers with low CIN index were moderately dierentiated adenocarcinomas, but a poorly dierentiated tumour was also observed.
Figure 2 Mean number of chromosomal changes plotted against heterogeneity score in primary sporadic colorectal cancers. Two pairs of tumours had identical score for both values (see Table 1 )
Figure 3 CIN index in RER7 and RER+ primary colorectal cancers and corresponding xenograft. RER7 p, RER7 primary tumours (black points); RER7 x, RER7 xenografts (grey points); RER+ p, RER+ primary tumours (black points); RER+ x, RER+ xenografts (grey points). Numbers shown against each point indicate sample ID, listed in Table 2 We next searched for dierences in the patterns of speci®c clonal chromosomal abnormalities present in low-and high-CIN index RER7 cancers. Analysis of chromosomal gains and losses in high-CIN index RER7 cancers revealed the most frequent changes to be 20q+, 18q7, 13q+, 8p7, 1p7 and 8q+. All of these changes were found, although less commonly, in the group of colorectal cancers with low CIN index (Table 3) . Particularly striking, however, was the low incidence of 13q duplication in RER7 tumours with 70 diploid n C asc.col./right poor yes yes n, p53 defect not detected by any of the three methods used; n*, IHC and mutation analysis negative, but p53 defect can not be excluded due to 17p loss detected by CGH; d, p53 defective (IHC or mutation analysis positive); des.col., descending colon; trs.col., transverse colon; sigm.col., sigmoid colon; asc.col., ascending colon low CIN index (detected in 1/6 tumours) compared with RER7 cancers with a high CIN index (10/11 tumours).
Comparison of primary tumours and xenografts
Analysis of RER+ primary tumours and their corresponding xenografts con®rmed that microsatellite instability is a dynamic process. Sampling at multiple sites revealed that, although many of the sites sampled showed altered alleles at two or more of the four microsatellite loci tested, the aected loci and the shifts observed were often dierent at dierent sites within the same tumour. Xenografts showed further changes still. Thus, in the xenografts from three tumours, 17 of 44 tested microsatellite loci acquired clonal alleles dierent from the primary tumour within a single passage in vivo (Table 4) .
To assess the progress of chromosomal changes, a scoring system similar to that for primary tumours was applied. For this purpose, we employed only those xenografts successfully established from at least two separate sites from the primary tumour (since this was a prerequisite for assessing the heterogeneity score). All of these tumours were either RER+ or RER7 with a high CIN index. CIN index increased between primary tumour and corresponding xenograft, particularly in RER7 cancers (Figure 3) , suggesting the presence of a potent mechanism of underlying chromosomal instability in those RER7 cancers which were established as xenografts. Interestingly, we failed completely to establish xenografts from all six of the RER7 tumours with low CIN index, despite implanting multiple samples from each.
Discussion
We have used a combination of microsatellite instability, DNA ploidy and comparative genomic hybridization patterns to classify human primary colorectal carcinomas in terms of genomic instability. A further indication of the character of this instability has been gained by comparison of multiple samples gathered from the same tumours, and assessment of certain tumours after several weeks' regrowth as subcutaneous xenografts in SCID mice. Three distinct phenotypes emerge. The ®rst ± the RER+ phenotype ± has been documented many times, both in primary tumours and cell lines. We con®rm here the strikingly The number of such events per genome was low, however, as was the extent to which such chromosome structural changes varied in time or between adjacent sites within the same tumour. The second phenotype is characterized by high incidence of chromosome arm ampli®cation or deletion, as detected by CGH. These tumours are invariably RER7, and the chromosome instability clearly re¯ects a continuing state rather than the result of a catastrophic event early in tumour history: plurality and divergence of clonal chromosomal changes are evident both between adjacent sites and during growth in time. Although the chromosomal abnormalities in this group favour particular sites (which we have documented in more detail elsewhere), no chromosome arm is free from abnormality in the group as a whole, and the studies with xenografts clearly show that chromosomes that were normal in the primary tumour can appear as ampli®ed or deleted in clonal outgrowths sampled only a few weeks later. This group probably corresponds broadly to the high CIN subgroup described by Lengauer et al. (1997) , on the basis of counts of a restricted set of chromosomespeci®c centromeres. The CIN score developed here, however, detects a wider range of structural chromosome abnormalities, since the CGH method takes account of all chromosomes, and detects ampli®cations and deletions within chromosome arms as well as nondisjunctive lesions involving whole chromosomes. Unsurprisingly, all the tumours assigned to this group on the basis of their aberrant CGH pro®les were also DNA aneuploid as assessed by¯ow cytometry.
The third phenotype combines RER7 status with a propensity for change in chromosome arms as low as that in most RER+ tumours. For several reasons it is most improbable that these tumours are merely misclassi®ed with respect to their RER status. The interrogated microsatellite sites included some of the most labile currently known, all the tumours were leftsided (most were rectal) and none showed mucinous dierentiation. Neither is it probable that these tumours merely represent temporally early versions of the high CIN, RER7 group. Of the six tumours assigned to this group, four had penetrated the muscle layer, three had lymph node metastases and all exceeded 3 cm in diameter at the time of study. Although there were some exceptions, many of the tumours in this group were near-diploid in DNA content. Thus, we consider it likely that these tumours arise by a pathway dierent from both the aneuploid RER7 and the RER+ groups. Although our studies have not delineated a mutational mechanism, the neardiploid CGH patterns could accommodate point mutation, gene conversion, deletions and ampli®cations below the limits of resolution of CGH, balanced translocations or uniparental disomy.
We suspect that the RER7 low CIN phenotype may be under-represented amongst currently available colorectal cancer cell lines, as RER7 near-diploid lines are rare (Eshleman et al., 1998) . A recent study of primary tumours, however, has also identi®ed a substantial subset of RER7 colorectal carcinomas with diploid DNA content and therefore probably low CIN phenotype (Yao et al., 1999) . It may be that these tumours either fail to adapt to growth in vitro or, in doing so, undergo obligatory further changes in chromosome structure. In this respect, we were interested to note that none of our RER7 low CIN tumours adapted to growth as xenografts, in contrast to RER7 high CIN tumours and RER+ tumours studied around the same time.
Further work with large numbers of cases will be required to establish whether RER7 low CIN tumours share a particular clinicopathological identity. It appears probable, however, that each of the three phenotypes described here arises because of de®ciency in dierent checkpoint mechanisms. For RER+ tumours, the critical defect (failed recognition of DNA nucleotide mismatches) is known, but the corresponding defect or defects for the RER7 tumour groups are still largely unknown. Information on this topic will be important, as it may be predictive of the ecacy of various therapeutic measures.
Materials and methods
Tissue samples
Fresh tissue samples were collected from consecutive sporadic colorectal carcinomas removed at operation between April and November 1997. Blocks of fresh tissue, approximately 106565 mm, were collected from two to four dierent sites, depending on the size of the tumour, from each colorectal cancer and one from normal mucosa at a point distant from the lesion. All tumours were from separate individuals except two (9 and 9') which occurred synchronously. Each block of tissue was subsequently divided into three separate pieces: the ®rst for DNA extraction and¯ow cytometry, the second for periodate-lysine-paraformaldehyde-dichromate (PLPD) ®xa-tion, and the third for xenografting (normal tissue was not xenografted). Sections from PLPD-®xed paran blocks were used for immunohistochemical detection of stabilized p53 protein and haematoxylin and eosin (H+E) staining for histological assessment. DNA was extracted from frozen tissue according to the method of Goelz et al. (1985) .
Establishment of colorectal cancer xenografts in SCID mice
Xenografts were established from dorsal implants of freshly obtained tissue fragments, as previously described (McQueen et al., 1991) but using severe combined immuno-de®cient (SCID) mice as recipients. Tumours were allowed to grow until an externally visible diameter of about 1 cm was reached, and were then passaged to new hosts. At the time of passage, the mice were killed and the tumour tissue divided into pieces for DNA extraction,¯ow cytometry and PLPD ®xation. H+E staining and immunohistochemical detection of stabilized p53 protein was carried out on ®xed tissue. Implantation was attempted from each of the cohort of 74 tumour samples, of which 26 were successfully established as xenografts. Time to ®rst passage varied between 3 and 20 weeks.
Flow cytometry
Frozen tissue was prepared for¯ow cytometry according to the method of Vindelov et al. (1983) . Flow cytometry was performed on an EPICS-XL¯ow cytometer (Coulter Electronics Ltd, Luton, UK) at an excitation wavelength of 488 nm. At least 5000 nuclei were analysed in each sample, and tumour DNA content estimated by comparison with identical analyses of normal tissue. Tumour samples were scored as`DNA diploid' or`DNA aneuploid' using previously described criteria (Carder et al., 1993) .
Immunohistochemical detection of stabilized p53 protein
Immunohistochemistry was carried out on 3 mm paran sections using the DO-7 antibody (Dako Ltd, UK) and an avidin-biotinylated horseradish peroxidase complex detection system (ABComplex/HRP, Dako Ltd, UK), with 3,3'-diaminobenzidine (DAB) as substrate, as previously described (Purdie et al., 1991) . Tumours were classi®ed as p53 defective if more than 10% nuclei showed intense positive staining.
Mutation analysis of the p53 gene
Mutation analysis of the p53 gene was performed on 15 tumours with faint, sparse or negative immunohistochemical staining to exclude the possibility of mutation not detectable by IHC. Previous studies have indicated that mutation in the p53 gene, if present, occurs relatively early in tumour progression and therefore can be readily detected in any part of the tumour (Carder et al., 1995) . For this reason, a single sample was taken as representative of each tumour. Exons 5 ± 8, in which 90% of all mutations are located (Levine et al., 1991) , were ampli®ed using the primers listed in Table 5 . Reactions were carried out in 50 ml volumes consisting of 200 ng genomic DNA, 0.5 mM of each primer, 200 mM of each dNTP, 1.5 mM MgCl 2 , 16PCR buer solution (Life Technologies Ltd, UK) and 1.25 U of thermostable DNA polymerase (Life Technologies Ltd, UK) with the addition of 50 ng g 33 PdATP-labelled primer to each reaction in the ®nal cycles.
SSCP with autoradiographic detection were undertaken as previously described (Carder et al., 1995) . Autoradiographs were assessed visually for shifts in electrophoretic mobility of ampli®ed sequences compared to DNA from normal tissue of the same patient.
Analysis of microsatellite instability
Two dinucleotide repeat sequences, D2S123 and D13S160 (Gyapay et al., 1994) and two poly(A) tracts, BAT-26 (Hoang et al., 1997) and the (A) 10 repeat in exon 3 of TGFb RII (using primers CCTCGCTTCCAATGAATCTC and TTGGCACAGATCTCAGGTCC), were analysed for evidence of microsatellite instability. All four loci were examined in each sampled site of 22 primary tumours and in all xenografts. Reactions were carried out as described above, with the addition of 10% DMSO, for all loci except BAT-26, where a ®nal concentration of 100 mM of each dNTP with 450 ng genomic DNA template was employed, and TGFb RII, where magnesium ion concentration was 4 mM. D2S123, D13S160 and poly(A) BAT-26 PCR products were heatdenatured and run on denaturing polyacrylamide gels to detect shifts in electrophoretic mobility. The (A) 10 sequence in exon 3 of TGF-b RII was assessed using SSCP as described above. Autoradiographs were assessed visually for the presence of shifts in electrophoretic mobility, comparing sequences from tumour samples and the corresponding normal DNA. Tumours were classi®ed as RER+ if they displayed band shifts at two or more loci.
Analysis of imbalanced chromosomal abnormalities using comparative genomic hybridization CGH was carried out using a method modi®ed from Kallioniemi et al. (1992) . Brie¯y, DNA was labelled by nick translation with biotin (tumour DNA) and digoxigenin (normal DNA), 500 ng of each prehybridized with 15 mg of human Cot-1 DNA, denatured and hybridized to a denatured normal male metaphase preparation for 2 ± 3 days. Detection was carried out using avidin-FITC and anti-digoxigenin-rhodamine and slides were additionally stained with 4,6-diamidino-2-phenylindole (DAPI) to allow chromosome identi®cation. Hybridizations were analysed using the Quantitative Image Processing System (QUIPS) software (Vysis Ltd, Richmond, Surrey, UK) coupled to a Zeiss Axioskop 20¯uorescence microscope (Carl Zeiss Ltd, Welwyn Garden City, UK) equipped with a SenSys CCD camera (Photometrics, Tucson, AZ, USA) and a triple bandpass ®lter set for detection of rhodamine,¯uorescein and DAPI. At least ®ve metaphase spreads were analysed from each slide. Because sex chromosomes might be under dierent selection pressure in tumours derived from males and females they were excluded from analysis. The ratios of 1.125 and 0.875 were used for scoring chromosomal gains and losses, ratios at which copy number changes could easily be visualized by eye. The same ratios were used for both primary tumours and xenografts, which could result in scoring of fewer chromosomal changes in the primary tumours due to contamination with normal stromal DNA. However, direct comparison of RER7 and RER+ cancers could be made since the same error applied to both groups.
